Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis
NCT ID: NCT01668589
Last Updated: 2018-01-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1501 participants
OBSERVATIONAL
2011-11-28
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice
NCT01652690
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
NCT02732210
Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
NCT02347865
Preventing Osteoporosis Using Denosumab
NCT02753283
A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis
NCT04664959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Enrolled into the study within 4 weeks of receiving their first injection of Prolia® according to the approved Regional Prescribing Information (eg, EU SmPC in Germany, Austria, Greece and Belgium).
* Appropriate written informed consent has been obtained (as required per local country regulations).
Exclusion Criteria
* Contraindicated for treatment with Prolia® according to the approved Regional Prescribing Information (eg, EU SmPC in Germany, Austria, Greece and Belgium).
* Participation in ongoing or previous denosumab clinical trials.
* Patient has any kind of disorder that, in the opinion of the investigator, may compromise the ability of the patient to give written informed consent.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amgen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MD
Role: STUDY_DIRECTOR
Amgen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Graz, , Austria
Research Site
Graz, , Austria
Research Site
Klagenfurt, , Austria
Research Site
Landeck, , Austria
Research Site
Leibnitz, Styria, , Austria
Research Site
Lieboch, , Austria
Research Site
Salzburg, , Austria
Research Site
Sankt Stefan, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Vienna, , Austria
Research Site
Voitsberg, , Austria
Research Site
Vöcklabruck, , Austria
Research Site
Aalst, , Belgium
Research Site
Aarschot, , Belgium
Research Site
Alsemberg, , Belgium
Research Site
Baisy-Thy, , Belgium
Research Site
Blankenberge, , Belgium
Research Site
Bornem, , Belgium
Research Site
Brain-Le-Comte, , Belgium
Research Site
Bruges, , Belgium
Research Site
Brussels, , Belgium
Research Site
Brussels, , Belgium
Research Site
Chênée, , Belgium
Research Site
Dour, , Belgium
Research Site
Eisden Maasmechelen, , Belgium
Research Site
Genk, , Belgium
Research Site
Ghent, , Belgium
Research Site
Gribomont, , Belgium
Research Site
Grimbergen, , Belgium
Research Site
Haine-Saint-Paul, , Belgium
Research Site
Halen, , Belgium
Research Site
Ham, , Belgium
Research Site
Ham-sur-Heure, , Belgium
Research Site
Harelbeke, , Belgium
Research Site
Hasselt, , Belgium
Research Site
Heusden, , Belgium
Research Site
Heusy, , Belgium
Research Site
Hoeilaart, , Belgium
Research Site
Knokke-Heist, , Belgium
Research Site
Kortrijk, , Belgium
Research Site
Kraainem, , Belgium
Research Site
Landen, , Belgium
Research Site
Leuven, , Belgium
Research Site
Liège, , Belgium
Research Site
Lummen, , Belgium
Research Site
Marchovelette, , Belgium
Research Site
Mont-Godinne, , Belgium
Research Site
Mont-sur-Marchienne, , Belgium
Research Site
Mouscron, , Belgium
Research Site
Natoye, , Belgium
Research Site
Paal-Beringen, , Belgium
Research Site
Retie, , Belgium
Research Site
Seraing, , Belgium
Research Site
Steenokkerzeel, , Belgium
Research Site
Stoumont, , Belgium
Research Site
Thuilles, , Belgium
Research Site
Tongeren, , Belgium
Research Site
Vilvoorde, , Belgium
Research Site
Vlijtingen-Riemst, , Belgium
Research Site
Wetteren, , Belgium
Research Site
Aachen, , Germany
Research Site
Augsburg, , Germany
Research Site
Bad Kreuznach, , Germany
Research Site
Bad Reichenhall, , Germany
Research Site
Bammental, , Germany
Research Site
Bautzen, , Germany
Research Site
Berlin, , Germany
Research Site
Berlin, , Germany
Research Site
Berlin, , Germany
Research Site
Berlin, , Germany
Research Site
Cottbus, , Germany
Research Site
Düsseldorf, , Germany
Research Site
Dresden, , Germany
Research Site
Erfurt, , Germany
Research Site
Erlangen, , Germany
Research Site
Freiburg im Breisgau, , Germany
Research Site
Freudenstadt, , Germany
Research Site
Friedrichroda, , Germany
Research Site
Hamburg, , Germany
Research Site
Hamburg, , Germany
Research Site
Hamburg, , Germany
Research Site
Hanover, , Germany
Research Site
Hattingen, , Germany
Research Site
Heidelberg, , Germany
Research Site
Heinsberg, , Germany
Research Site
Herne, , Germany
Research Site
Hettstedt, , Germany
Research Site
Hildesheim, , Germany
Research Site
Immenstadt im Allgäu, , Germany
Research Site
Lahnstein, , Germany
Research Site
Leipzig, , Germany
Research Site
Leipzig, , Germany
Research Site
Leverkusen, , Germany
Research Site
Marburg, , Germany
Research Site
Müllheim, , Germany
Research Site
München, , Germany
Research Site
München, , Germany
Research Site
München, , Germany
Research Site
Münster, , Germany
Research Site
Mönchengladbach-Rheydt, , Germany
Research Site
Nürnbrecht, , Germany
Research Site
Neustadt, , Germany
Research Site
Nienburg, , Germany
Research Site
Osnabrück, , Germany
Research Site
Potsdam, , Germany
Research Site
Saarbrücken, , Germany
Research Site
Stockach, , Germany
Research Site
Ulm, , Germany
Research Site
Völklingen, , Germany
Research Site
Wadgassen, , Germany
Research Site
Würzburg, , Germany
Research Site
Wittstock, , Germany
Research Site
Zerbst, , Germany
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Athens, , Greece
Research Site
Chaidari, Athens, , Greece
Research Site
Chania, Crete, , Greece
Research Site
Heraklion, , Greece
Research Site
Heraklion, Crete, , Greece
Research Site
Livadeia, , Greece
Research Site
Maroussi, Athens, , Greece
Research Site
Pátrai, , Greece
Research Site
Pátrai, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Thessaloniki, , Greece
Research Site
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fahrleitner-Pammer A, Papaioannou N, Gielen E, Feudjo Tepie M, Toffis C, Frieling I, Geusens P, Makras P, Boschitsch E, Callens J, Anastasilakis AD, Niedhart C, Resch H, Kalouche-Khalil L, Hadji P. Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium. Arch Osteoporos. 2017 Dec;12(1):58. doi: 10.1007/s11657-017-0351-2. Epub 2017 Jun 22.
Related Links
Access external resources that provide additional context or updates about the study.
AmgenTrials clinical trials website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20110126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.